Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Current Assets (2022 - 2025)

Historic Current Assets for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $207.8 million.

  • Phathom Pharmaceuticals' Current Assets fell 4441.64% to $207.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.8 million, marking a year-over-year decrease of 4441.64%. This contributed to the annual value of $360.1 million for FY2024, which is 938.48% down from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Current Assets stood at $207.8 million for Q3 2025, which was down 4441.64% from $218.9 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Current Assets ranged from a high of $397.4 million in Q4 2023 and a low of $139.8 million during Q1 2023
  • For the 4-year period, Phathom Pharmaceuticals' Current Assets averaged around $253.7 million, with its median value being $226.7 million (2023).
  • As far as peak fluctuations go, Phathom Pharmaceuticals' Current Assets surged by 14760.27% in 2023, and later crashed by 4441.64% in 2025.
  • Phathom Pharmaceuticals' Current Assets (Quarter) stood at $160.5 million in 2022, then surged by 147.6% to $397.4 million in 2023, then dropped by 9.38% to $360.1 million in 2024, then crashed by 42.3% to $207.8 million in 2025.
  • Its Current Assets stands at $207.8 million for Q3 2025, versus $218.9 million for Q2 2025 and $264.9 million for Q1 2025.